Processa Pharmaceuticals Inc (PCSA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.23
• Market Cap: $4.76M
• EPS: $-28.75
• 52-Week High: $19.62
• 52-Week Low: $1.76

Market Sentiment

Processa Pharmaceuticals Inc currently has a Bullish sentiment score of 0.21.

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Hanover, Maryland, focused on developing innovative therapies to address unmet medical needs. The company specializes in advancing its proprietary drug candidates through clinical trials, specifically targeting diseases with limited or ineffective treatment options. With a commitment to tackling significant health challenges, Processa aims to enhance patient outcomes and quality of life. As it navigates its ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Processa Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PCSA pay dividends?

Processa Pharmaceuticals Inc (PCSA) does not currently pay a regular dividend.

What is PCSA's market cap?

Processa Pharmaceuticals Inc (PCSA) has a market capitalization of $4.76M with a current stock price of $2.23.